Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiple Functions and Mechanisms Underlying the Role of METTL3 in Human Cancers
Wenhui Zheng, Xiaoshen Dong, Yan Zhao, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 83

Showing 26-50 of 83 citing articles:

m6A methyltransferase WTAP regulates myocardial ischemia reperfusion injury through YTHDF1/FOXO3a signaling
Hui Wang, Liujing Fu, Yin Li, et al.
APOPTOSIS (2023) Vol. 28, Iss. 5-6, pp. 830-839
Closed Access | Times Cited: 15
Multi-omic analyses of m5C readers reveal their characteristics and immunotherapeutic proficiency
Rui Xu, Yue Wang, Ye Kuang
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Exploration of mRNA-modifying METTL3 oncogene as momentous prognostic biomarker responsible for colorectal cancer development
Muhammad Naveed, Muhammad Saad Mughal, Tariq Aziz, et al.
Open Medicine (2025) Vol. 20, Iss. 1
Open Access
CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells
Xiaoxue Jiang, Libo Xing, Yingjie Chen, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 23, pp. 310-323
Open Access | Times Cited: 38
Towards a druggable epitranscriptome: Compounds that target RNA modifications in cancer
María Berdasco, Manel Esteller
British Journal of Pharmacology (2021) Vol. 179, Iss. 12, pp. 2868-2889
Open Access | Times Cited: 29
METTL3-induced UCK2 m6A hypermethylation promotes melanoma cancer cell metastasis via the WNT/β-catenin pathway
Hao Wu, Haochao Xu, Dong‐Dong Jia, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 14, pp. 1155-1155
Open Access | Times Cited: 29
Effect of m6A methyltransferase METTL3 ‐mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer
Sumei Li, Fengru Jiang, Feiyu Chen, et al.
Journal of Biochemical and Molecular Toxicology (2021) Vol. 36, Iss. 1
Closed Access | Times Cited: 29
METTL3 Is Associated With the Malignancy of Esophageal Squamous Cell Carcinoma and Serves as a Potential Immunotherapy Biomarker
Yubin Zhou, Songhe Guo, Yiqiu Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 21
RNA methylation in hematological malignancies and its interactions with other epigenetic modifications
Lan Yao, Hua Yin, Mei Hong, et al.
Leukemia (2021) Vol. 35, Iss. 5, pp. 1243-1257
Open Access | Times Cited: 26
Role of m6A in osteoporosis, arthritis and osteosarcoma (Review)
Yibo Hu, Xiaohui Zhao
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 3
Open Access | Times Cited: 26
Multi-dimensional structural footprint identification for the design of potential scaffolds targeting METTL3 in cancer treatment from natural compounds
Abdul Rashid Issahaku, Samukelisiwe Minenhle Mncube, Clement Agoni, et al.
Journal of Molecular Modeling (2023) Vol. 29, Iss. 4
Closed Access | Times Cited: 9
De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy
Peng Lu, Yun Xu, Zhi-yong Sheng, et al.
Experimental Cell Research (2021) Vol. 406, Iss. 1, pp. 112761-112761
Closed Access | Times Cited: 22
The Role of N6-Methyladenosine (m6A) Methylation Modifications in Hematological Malignancies
Yan Zhao, Hongling Peng
Cancers (2022) Vol. 14, Iss. 2, pp. 332-332
Open Access | Times Cited: 15
Role of methyltransferase-like enzyme 3 and methyltransferase-like enzyme 14 in urological cancers
Zijia Tao, Yiqiao Zhao, Xiaonan Chen
PeerJ (2020) Vol. 8, pp. e9589-e9589
Open Access | Times Cited: 21
Methyltransferase-like 3 induces the development of cervical cancer by enhancing insulin-like growth factor 2 mRNA-binding proteins 3-mediated apoptotic chromatin condensation inducer 1 mRNA stability
Cui-Hong Su, Yan Zhang, Ping Chen, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7034-7048
Open Access | Times Cited: 13
Small molecules that regulate the N6-methyladenosine RNA modification as potential anti-cancer agents
Noah J. Harrahill, M. Kyle Hadden
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116526-116526
Closed Access | Times Cited: 2
A five-m6A regulatory gene signature is a prognostic biomarker in lung adenocarcinoma patients
Xiao Wu, Hongxu Sheng, Luming Wang, et al.
Aging (2021) Vol. 13, Iss. 7, pp. 10034-10057
Open Access | Times Cited: 15
Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice
Tarek K. Motawi, Shohda A. El‐Maraghy, Dina Sabry, et al.
Chemico-Biological Interactions (2022) Vol. 365, pp. 110094-110094
Closed Access | Times Cited: 10
RBM15 condensates modulate m6A modification of STYK1 to promote tumorigenesis
Amin Jiang, Siwei Zhang, Xinyu Wang, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 4825-4836
Open Access | Times Cited: 10
Prognostic Roles of N6-Methyladenosine METTL3 in Different Cancers: A System Review and Meta-Analysis
Kuangzheng Liu, Yue Gao, Kai Gan, et al.
Cancer Control (2021) Vol. 28
Open Access | Times Cited: 13
Effect, Mechanism, and Applications of Coding/Non-coding RNA m6A Modification in Tumor Microenvironment
Chaohua Si, Chen Chen, Yaxin Guo, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 13
Polymorphisms in METTL3 gene and hepatoblastoma risk in Chinese children: A seven-center case-control study
Huitong Chen, Fei Duan, Mi Wang, et al.
Gene (2021) Vol. 800, pp. 145834-145834
Closed Access | Times Cited: 12
Methyltransferase‐like 3 promotes the progression of lung cancer via activating PI3K/AKT/mTOR pathway
Feng‐Wu Cheng, Li‐Ming Peng, Dan Luo
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 49, Iss. 7, pp. 748-758
Closed Access | Times Cited: 8
miR-33a-5p Suppresses ox-LDL-Stimulated Calcification of Vascular Smooth Muscle Cells by Targeting METTL3
Ruimei Han, Jian Luo, Lingpeng Wang, et al.
Cardiovascular Toxicology (2021) Vol. 21, Iss. 9, pp. 737-746
Closed Access | Times Cited: 11
Hsa_circ_0001658 accelerates the progression of colorectal cancer through miR-590-5p/METTL3 regulatory axis
Yang Lu, Xingming Wang, Zeshu Li, et al.
World Journal of Gastrointestinal Oncology (2023) Vol. 15, Iss. 1, pp. 76-89
Open Access | Times Cited: 4

Scroll to top